|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$96.50 |
$97.49 |
$95.16 |
$95.20 |
9.80M | 03/22/2024 |
$95.22 |
$95.38 |
$93.50 |
$93.56 |
10.42M | 03/25/2024 |
$93.37 |
$94.47 |
$92.50 |
$92.67 |
8.75M | 03/26/2024 |
$93.88 |
$94.46 |
$92.66 |
$92.69 |
10.80M | 03/27/2024 |
$93.55 |
$94.92 |
$92.45 |
$94.91 |
12.28M |
|
SPDR S&P Biotech is an open-end investment management company. The Fund seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. As of June 30 2015, the Fund's total assets and investment porfolio totaled $3,360,344,396 and $3,327,690,681, respectively. | |
|
SPDR Series Trust - S&P Biotech ETF (XBI) has the following price history information. Looking back at XBI historical stock prices for the last five trading days, on March 21, 2024, XBI opened at $96.50, traded as high as $97.49 and as low as $95.16, and closed at $95.20. Trading volume was a total of 9.80M shares. On March 22, 2024, XBI opened at $95.22, traded as high as $95.38 and as low as $93.50, and closed at $93.56. Trading volume was a total of 10.42M shares. On March 25, 2024, XBI opened at $93.37, traded as high as $94.47 and as low as $92.50, and closed at $92.67. Trading volume was a total of 8.75M shares. On March 26, 2024, XBI opened at $93.88, traded as high as $94.46 and as low as $92.66, and closed at $92.69. Trading volume was a total of 10.80M shares. On March 27, 2024, XBI opened at $93.55, traded as high as $94.92 and as low as $92.45, and closed at $94.91. Trading volume was a total of 12.28M shares.
XBI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into SPDR Series Trust - S&P Biotech ETF shares, starting with a $10,000 purchase of XBI, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$47.49 |
|
End price/share: |
$94.91 |
|
Starting shares: |
210.57 |
|
Ending shares: |
216.11 |
|
Dividends reinvested/share: |
$1.88 |
|
Total return: |
105.11% |
|
Average Annual Total Return: |
7.45% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$20,510.62 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$47.49 |
|
End price/share: |
$94.91 |
|
Dividends collected/share: |
$1.88 |
|
Total return: |
103.82% |
|
Average Annual Total Return: |
7.38% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$20,377.42 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $95.20 | 03/22/2024 | $93.56 | 03/25/2024 | $92.67 | 03/26/2024 | $92.69 | 03/27/2024 | $94.91 |
|
|